ukwelashwa komdlavuza wamaphaphu amancane

Ukwelashwa komdlavuza wamaphaphu omncane izinketho zihluka kakhulu kuye ngokuthi umdlavuza ungakanani, impilo yesiguli iyonke, kanye nezinto ezithandwa umuntu. Lesi sihloko sihlola izindlela ezahlukene zokwelapha ezitholakalayo zomdlavuza omncane wamaphaphu, okuhlanganisa ukuhlinzwa, ukwelashwa ngemisebe, i-chemotherapy, ukwelashwa okuhlosiwe, kanye ne-immunotherapy. Sizoxoxa ngezinzuzo kanye nokubi kwenketho ngayinye, kanye nemiphumela engemihle engase ibe khona kanye nemiphumela yesikhathi eside. Ukuxilongwa kusenesikhathi kanye nokwelashwa kubalulekile ukuze kube ngcono amazinga okusinda.Ukuqonda Umdlavuza Wamaphaphu OmncaneUyini Umdlavuza Wamaphaphu Omncane (SCLC)?Umdlavuza wamaphaphu wamangqamuzana amancane (SCLC) uwuhlobo olukhula ngokushesha lomdlavuza wamaphaphu olwakha cishe u-10-15% wawo wonke umdlavuza wamaphaphu. Ihlotshaniswa kakhulu nokubhema futhi ijwayele ukusabalala ngokushesha kwezinye izingxenye zomzimba. Ngenxa yemvelo yayo enolaka, ukuhlonzwa kusenesikhathi kanye nokwelashwa ngokushesha kubalulekile.Izigaba Zomdlavuza Wamaphaphu Amangqamuzana AmancaneSCLC ngokuvamile ihlukaniswa ngezigaba ezimbili:Isiteji Esinomkhawulo: Umdlavuza uvalelwe ohlangothini olulodwa lwesifuba kanye nama-lymph nodes aseduze.Isiteji Esibanzi: Umdlavuza ususabalele ngaphesheya kwesifuba, kuma-lymph nodes akude, noma kwezinye izitho.Ukwelashwa Komdlavuza Wamaphaphu Amancane IzinkethoIndlela yokwelapha ye-SCLC incike esigabeni somdlavuza. I-Shandong Baofa Cancer Research Institute izinikele ekuhlinzekeni ukunakekelwa komdlavuza okuthuthuke kakhulu futhi okuphelele.Ukwelashwa Kwesigaba Esilinganiselwe I-SCLCUkwelashwa okuyinhloko kwe-SCLC yesigaba esilinganiselwe kuvame ukubandakanya inhlanganisela yalokhu okulandelayo:I-Chemotherapy: I-Chemotherapy isebenzisa izidakamizwa ukubulala amangqamuzana omdlavuza kuwo wonke umzimba. Ngokuvamile ulayini wokuqala wokwelapha we-SCLC.Ukwelapha ngemisebe: Ukwelapha ngemisebe kusebenzisa imisebe enamandla amakhulu ukukhomba nokubhubhisa amangqamuzana omdlavuza endaweni ethile. Ivame ukusetshenziswa kanye ne-chemotherapy.Ukuhlinzwa: Ezimweni ezingavamile, ukuhlinzwa kungase kube inketho yokukhipha isimila, ikakhulukazi uma sisincane futhi singasakazeki. Kodwa-ke, i-SCLC ayivamisile ukuphathwa ngokuhlinzwa kuphela.Ukwelashwa Kwesiteji Esibanzi SCLCTUkwelashwa kwe-SCLC yesiteji esibanzi ngokuvamile kugxile ekulawuleni ukusabalala komdlavuza kanye nokunciphisa izimpawu. Izinketho zifaka:I-Chemotherapy: I-Chemotherapy isalokhu iyinsika yokwelashwa kwe-SCLC yesiteji esikhulu.I-Immunotherapy: I-Immunotherapy isebenzisa izidakamizwa ukusiza amasosha omzimba ukulwa nomdlavuza. Ingase isetshenziswe ngokuhambisana ne-chemotherapy.Ukwelapha ngemisebe: Ukwelapha ngemisebe kungasetshenziswa ukuze kudambise izimpawu ezinjengobuhlungu noma ukuphelelwa umoya, noma ukunciphisa izimila ezicindezela izitho ezibalulekile.Ukunakekelwa kwe-Palliative: Ukunakekelwa kwe-Palliative kugxile ekulawuleni izimpawu kanye nokwenza ngcono izinga lempilo yeziguli ezinomdlavuza oseqophelweni eliphezulu.Specific Ukwelashwa Komdlavuza Wamaphaphu Amancane I-ModalitiesChemotherapy ye-SCLCChemotherapy ukwelashwa okuhlelekile, okusho ukuthi kuthinta wonke umzimba. Izidakamizwa ezijwayelekile ze-chemotherapy ezisetshenziselwa i-SCLC zifaka i-cisplatin noma i-carboplatin, ne-etoposide. Imiphumela engemihle ingase ihlanganise isicanucanu, ukuhlanza, ukuqothuka kwezinwele, ukukhathala, kanye nengozi eyengeziwe yokutheleleka. Le miphumela engemihle ingalawuleka ngemithi yokunakekela esekelayo.Ukwelashwa ngemisebe ye-SCLCRadiation therapy ingalethwa ngaphandle kusetshenziswa umshini ohlose imisebe yemisebe esimila noma ngaphakathi kusetshenziswa izinto ezikhipha imisebe ezibekwe eduze kwesimila. Imiphumela engemihle yokwelashwa ngemisebe ingase ihlanganise ukucasuka kwesikhumba, ukukhathala, nobunzima bokugwinya, kuye ngendawo ephathwayo.I-Immunotherapy yezidakamizwa ze-SCLCImmunotherapy, njenge-pembrolizumab ne-atezolizumab, ibonise isithembiso ekwelapheni i-SCLC, ikakhulukazi ngokuhlanganiswa ne-chemotherapy. Le mithi isebenza ngokuvimbela amaprotheni avimbela amasosha omzimba ekuhlaseleni amangqamuzana omdlavuza. Imiphumela engemihle ingase ihlanganise ukukhathala, ukuqubuka, isifo sohudo, kanye nokusabela kokuzivikela komzimba.Ukwelashwa okuhlosiwe kwe-SCLCImithi yokwelapha ehlosiwe iqondise ama-molecule athile noma izindlela ezihilelekile ekukhuleni kwamangqamuzana omdlavuza nokuphila. Nakuba izindlela zokwelapha ezihlosiwe ziguqule ukwelashwa kwezinye izinhlobo zomdlavuza, azikasetshenziswa kabanzi ku-SCLC. Ucwaningo lusaqhubeka ukuze kuhlonzwe okungase kube okuhlosiwe kanye nokuthuthukisa izindlela zokwelapha eziqondiswe ngempumelelo zalesi sifo.Isivivinyo Semitholampilo sa Ukwelashwa Komdlavuza Wamaphaphu AmancaneIzivivinyo zemitholampilo ziyizifundo zocwaningo ezihlola izindlela zokwelapha ezintsha noma izinhlanganisela zokwelapha. Iziguli ezine-SCLC zingacabanga ukubamba iqhaza ezivivinyweni zomtholampilo ukuze zifinyelele ekwelashweni kwesimanjemanje okungakatholakali kabanzi. Khuluma nodokotela wakho mayelana nokuthi isilingo somtholampilo sikulungele yini. Ungathola ulwazi olwengeziwe ku- Iwebhusayithi yeNational Cancer Institute.Ukuphatha Imiphumela Emibi ye Ukwelashwa Komdlavuza Wamaphaphu AmancaneUkwelashwa komdlavuza wamaphaphu omncane kungabangela uhla lwemiphumela emibi. Kubalulekile ukuxhumana ngokukhululekile nethimba lakho lezempilo mayelana nanoma yimiphi imiphumela emibi oyitholayo ukuze ilawulwe ngempumelelo. Imiphumela emibi evamile kanye namasu okuphatha afaka:Isicanucanu nokuhlanza: Imithi yokulwa nesicanucanu ingasiza ekudambiseni lezi zimpawu.Ukukhathala: Ukuphumula, ukuvivinya umzimba okuncane, nokudla okunempilo kungasiza ekulawuleni ukukhathala.Ukuqothuka kwezinwele: Ukulahlekelwa izinwele kuwumphumela ovamile we-chemotherapy. Cabangela ukugqoka iwigi noma ukumboza ikhanda.Izilonda zomlomo: Ukuhlanzeka komlomo okuhle kanye nokugeza umlomo okukhethekile kungasiza ukuvimbela nokwelapha izilonda emlonyeni.Ayanda Ingozi Yokutheleleka: Gwema izixuku futhi ugeze izandla zakho njalo ukuze unciphise ingozi yokutheleleka.Survival Rates for Umdlavuza Wamaphaphu AmancaneAmazinga okusinda e-SCLC ayahlukahluka kuye ngesigaba somdlavuza nezinye izici. Ngokusho kwe I-American Cancer Society, izinga lokusinda leminyaka emi-5 le-SCLC yesigaba esilinganiselwe licishe libe ngu-27%, kuyilapho izinga lokusinda leminyaka emi-5 le-SCLC yesiteji esibanzi licishe libe ngu-3%. Kodwa-ke, lawa ama-avareji nje, futhi imiphumela ngayinye ingahluka kakhulu.Nasi isifinyezo samazinga okusinda ajwayelekile ngesigaba: Isigaba Seminyaka Emihlanu Yokusinda Kwesilinganiso Esilinganiselwe Isigaba. 27% Isigaba Esibanzi Esiyisilinganiso. 3% Ukubaluleka Kokutholwa KusenesikhathiNgoba i-SCLC iwumdlavuza onamandla, ukutholwa kusenesikhathi kubalulekile ukuze kuthuthukiswe amazinga okusinda. Uma unomlando wokubhema noma ezinye izici eziyingozi zomdlavuza wamaphaphu, khuluma nodokotela wakho mayelana nezinketho zokuzihlola, ezifana nezikena ze-CT ezinedosi eliphansi. IsiphethoUkwelashwa komdlavuza wamaphaphu omncane kuyinqubo eyinkimbinkimbi edinga indlela ehlukahlukene. Kubalulekile ukusebenzelana nochwepheshe abanolwazi nabanekhono. Uma kutholwe ukuthi une-SCLC, kubalulekile ukuxoxa ngazo zonke izindlela zokwelashwa nethimba lakho lezempilo ukuze wenze uhlelo lomuntu siqu olulungele wena. Iqembu ku I-Shandong Baofa Cancer Research Institute, eyaziwa nangokuthi Isibhedlela i-Baofa, sizinikele ekuhlinzekeni ukwelashwa komdlavuza wamaphaphu osezingeni eliphezulu kanye nokunakekela okunobubele. Khumbula ukuxoxa ngazo zonke izinketho ezitholakalayo ukwelashwa komdlavuza wamaphaphu amancane nethimba lakho lezokwelapha.